REPLIGEN CORPORATION
Updates & Highlights
Repligen Corporation - Common Stock (NQ: RGEN
Repligen Corporation - Common Stock (NQ: RGEN
FinancialContent · 2 days ago
Repligen Corporation (RGEN) Stock Analysis: Assessing a Potential 73.75% Upside in the Bioprocessing Innovator
Repligen Corporation (RGEN) Stock Analysis: Assessing a Potential 73.75% Upside in the Bioprocessing Innovator
DirectorsTalk Interviews · 3 days ago
Repligen Corporation - Common Stock (NQ: RGEN
Repligen Corporation - Common Stock (NQ: RGEN
FinancialContent · 7 days ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Generous PTO
Paid time off
401(k) Match
Retirement savings
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at RepliGen Corporation?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
10 recentRepligen Corporation - Common Stock (NQ: RGEN
Repligen Corporation - Common Stock (NQ: RGEN
FinancialContent · 2 days ago
Repligen Corporation (RGEN) Stock Analysis: Assessing a Potential 73.75% Upside in the Bioprocessing Innovator
Repligen Corporation (RGEN) Stock Analysis: Assessing a Potential 73.75% Upside in the Bioprocessing Innovator
DirectorsTalk Interviews · 3 days ago
Repligen Corporation - Common Stock (NQ: RGEN
Repligen Corporation - Common Stock (NQ: RGEN
FinancialContent · 7 days ago
Repligen Corporation stock hits 52-week low at $109.44 By Investing.com
Repligen Corporation stock hits 52-week low at $109.44 By Investing.com
Investing.com Nigeria · 8 days ago
Repligen Corporation stock hits 52-week low at $109.44
Repligen Corporation stock hits 52-week low at $109.44
Investing.com · 8 days ago
Repligen Corporation - Common Stock (Nasdaq:RGEN) Stock Quote
Repligen Corporation - Common Stock (Nasdaq:RGEN) Stock Quote
FinancialContent · 10 days ago
Repligen Corporation (RGEN): Investor Outlook Reveals 45.62% Potential Upside In Bioprocessing Innovator
Repligen Corporation (RGEN): Investor Outlook Reveals 45.62% Potential Upside In Bioprocessing Innovator
DirectorsTalk Interviews · 10 days ago
Barclays Maintains an “Overweight Rating” on Repligen Corporation (RGEN)
Barclays Maintains an “Overweight Rating” on Repligen Corporation (RGEN)
Yahoo Finance · 11 days ago
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
GlobeNewswire · 14 days ago
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
Yahoo Finance · 15 days ago